rs113371321
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The NM_000271.5(NPC1):c.3560C>T(p.Ala1187Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,613,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A1187A) has been classified as Benign.
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.3560C>T | p.Ala1187Val | missense_variant | 23/25 | ENST00000269228.10 | NP_000262.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.3560C>T | p.Ala1187Val | missense_variant | 23/25 | 1 | NM_000271.5 | ENSP00000269228.4 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251064Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135718
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461542Hom.: 1 Cov.: 30 AF XY: 0.0000591 AC XY: 43AN XY: 727080
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74502
ClinVar
Submissions by phenotype
Niemann-Pick disease, type C1 Uncertain:4
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 08, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1187 of the NPC1 protein (p.Ala1187Val). This variant is present in population databases (rs113371321, gnomAD 0.04%). This missense change has been observed in individual(s) with clinical features of Niemann-Pick Type C (PMID: 19252935, 31130284, 32138288). ClinVar contains an entry for this variant (Variation ID: 556002). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Ala1187 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26981555; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 06, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 05, 2018 | - - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 25, 2022 | Identified in adults with psychotic symptoms in published literature (Fancello et al., 2009; Sriretnakumar et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34426522, 19252935, 32138288, 31130284, 30556376, 34670123) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 29, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 18, 2023 | Variant summary: NPC1 c.3560C>T (p.Ala1187Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 251064 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in NPC1 causing Niemann-Pick Disease Type C (0.00012 vs 0.0027), allowing no conclusion about variant significance. c.3560C>T has been reported in the literature in individuals affected with clinical features of Niemann-Pick Type C (examples: Fancello_2009, Monies_2019, Sriretnakumar_2019, Dardis_2020, Chen_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Niemann-Pick Disease Type C. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30556376, 35861376, 32138288, 19252935, 31130284, 33138774). Seven submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.3560C>T (p.A1187V) alteration is located in exon 23 (coding exon 23) of the NPC1 gene. This alteration results from a C to T substitution at nucleotide position 3560, causing the alanine (A) at amino acid position 1187 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
NPC1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 09, 2024 | The NPC1 c.3560C>T variant is predicted to result in the amino acid substitution p.Ala1187Val. This variant has been reported in an individual with Niemann-Pick disease, type C (NPC) (Fancello et al. 2009. PubMed ID: 19252935) and has been reported in the homozygous state in an infant with fine and gross motor delay, speech delay, intellectual disability, white matter changes, and spasticity (Table S1, Monies et al. 2019. PubMed ID: 31130284). It has been reported in the homozygous state in a boy with infantile onset global developmental delay, microcephaly and dysmorphic features, biochemical studies did not support pathogenicity (Almenabawy et al. 2024. PubMed ID: 38549495). An alternate nucleotide change, p.Ala1187Gly, has been reported in the compound heterozygous state in an individual with NPC (Table S1, Reunert et al. 2015. PubMed ID: 26981555). This variant is reported in 0.045% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at